Joint Formulary & PAD

Propranolol hydrochloride - Arrhythmias

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Modified release capsules
  • Oral solution
  • Tablets
Associated Icons :
SPC
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Propranolol hydrochloride
Indication :
Arrhythmias
Group Name :
Keywords :
beta-blockers
Brand Names Include :
Bedranol, Half Beta-Prograne, Beta-Prograne
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Committee Recommendations (1)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.